The expression of aquaporins (AQPs) in the fetal porcine urinary tract and its relation to gestational age has not been established. (n=11) or 100 days (n=8). PCR showed that AQP1, 3, 9 and 11 mRNA was expressed in all locations. The expression of AQP3 increased significantly at all four locations with gestational age, whereas AQP11 significantly decreased. AQP1 expression increased in the ureter, bladder and urethra. AQP9 mRNA expression increased in the urethra and bladder, but decreased in the ureter. AQP5 was expressed only in the urethra.
Introduction
The urothelium covers the inner surface of the urinary tract and was for a long time considered an impermeable barrier, due to a very high trans-urothelial resistance. This is achieved by tight junctions between cells, as well as glycans, membrane lipids and uroplakins lining the umbrella cells (Hicks et al. 1974 , Lewis 2000 .
The functional role of the urothelium has been extensively investigated (Birder and Andersson 2013) , and with respect to its barrier function studies have shown changes in urine composition along the urinary tract and during storage in the bladder, but also passage of substances between blood and urine (Cahill et al. 2003 , Englund 1956 , Levinsky and Berliner 1959 , Shafik et al. 2006 , Shafik et al. 2005 , Shafik et al. 2004 , Walser et al. 1988 . Furthermore, there is evidence that the urothelium might be involved in sensing and signaling related to osmolality of the urine and bladder fullness (Andersson and McCloskey 2014 , Birder and Andersson 2013 , Rubenwolf et al. 2012b . The presence of membrane transporters in the urothelium, such as aquaporins (AQPs), has also been shown, suggesting a role in water reabsorption (Kim et al. 2010 , Rubenwolf et al. 2012b , Rubenwolf et al. 2009 , Spector et al. 2002 . Such a role Vol. 67 for the AQPs has been demonstrated in the adult mammalian kidney (Nielsen et al. 2000) , and in the skin and urinary bladder of amphibians (Suzuki and Tanaka 2009) . Recent studies show changes in AQP expression in the urothelium and lamina propria of the adult mammalian bladder following urothelial carcinoma (Rubenwolf et al. 2015) , bladder outlet obstruction or dehydration (Kim et al. 2010 , Kim et al. 2012 , Spector et al. 2002 , emphasizing the need for better understanding the role of AQPs in the urinary tract.
Pigs are often utilized as experimental animals for studies on urinary tract function as they share many physiological and anatomical features with humans (Crowe and Burnstock 1989) . However, little is known about the developmental physiology of the porcine urinary tract function. Olsen et al. (2001) studied bladder function urodynamically in porcine fetuses at 62 and 80 days of gestation (corresponding to mid second and early third trimester in human pregnancy), and demonstrated developmental changes in voiding function as the striated sphincter evolves. In adult rats a partial bladder outlet obstruction causes expression of AQP1, 2 and 3 to increase (Kim et al. 2012 , Kim et al. 2010 , Kim et al. 2013b . We speculate whether the sphincter development during fetal life has the same effect. Studies concerning the development of AQPs in the porcine kidney during gestation has been performed, showing an increased expression of AQP1, 2, and 3 (Xing and Nørregaard 2016), but studies on the urinary tract during development seem to be lacking and suitable animal models would be desirable.
The purpose of the present study was to gain basic knowledge about the expression of AQPs in the fetal porcine urinary tract, and how this expression relates to gestational age. We investigated the expression of AQPs in four different locations: the renal pelvis, the ureter, the bladder and the urethra, assuming that AQPs are expressed in the porcine urinary tract in a similar fashion as in humans.
Material and Methods
All procedures conformed to the Danish National Guidelines for care and handling of animals and to the published guidelines from the National Institute of Health. Experiments were carried out after ethical approval by the Danish Animal Experiments Inspectorate, Approval no. 2014-15-0201-00356. Pregnant sows, crossbred Danish Landrace/Yorkshire, inseminated with semen from Duroc boar, were obtained from a commercial source and sacrificed at different occasions by intravenous injection of pentobarbital at Aarhus University Foulum at 60 and 100 days of gestation (corresponding to mid second and late third trimester in humans). Average gestation length in these pigs is 114 days. The uterus was excised and opened, and the fetuses were weighed and necropsied.
Tissue handling
Access to the fetal urinary tract was obtained through midline sagittal and transverse laparotomy. The urachus was cut and held, and the bladder was excised, along with proximal urethra and distal ureters. Samples were taken from the proximal urethra and distal ureters, and either snap frozen in liquid nitrogen, or placed in 10 % formalin. Both kidneys were excised. A sample from the renal pelvis of one kidney was snap frozen. The contralateral kidney, including pelvis, was placed in 10 % formalin. All snap frozen samples were stored at -80 ºC until processing.
The bladders were handled in different ways:
• Whole wall tissue sample from the bladder dome was taken and snap frozen for RNA-extraction, whole bladders were snap frozen for protein extraction.
• Bladders for immunohistochemistry were either pin-mounted on a cork plate and placed in 10 % formalin, or filled with 1-2 ml of formalin, via a 17G catheter inserted through the urachus, after applying metal clips to close ureters and urethra. Filled bladders were subsequently submerged in 10 % formalin.
• Some of the bladders were selected for use in another project.
RNA extraction and PCR analysis
Total RNA was isolated from the frozen samples using TRIzol® (ThermoFischer ScientificTM, Waltham, USA) and chloroform/isopropanol extraction. cDNA was synthesized from 0.5 µg RNA with the RevertAid First Strand cDNA Synthesis kit® (Thermo ScientificTM, MBI Fermentas, Burlington, Canada). Primers were designed for AQPs 1-11 and four reference genes. Reference genes were chosen based on the literature (Nygard et al. 2007 , Xu et al. 2015 , previous experience and results from validation of stable expression across gestation. RT-PCR was performed for all AQPs along with positive control tissue samples and distilled water serving as a negative control. Primer sequences and positive control tissues are shown in Table 1 . PCR products were analyzed by electrophoresis in a 1 % agarose gel at 100 V for 60 min.
Supplementary quantitative PCR was performed for relevant AQPs and reference genes on all samples that were positive in RT-PCR, using the Maxima® SYBR® Green QPCR Master Mix (ThermoFischer ScientificTM) according to manufacturer's instruction. Duplicate samples were amplified in 96-well plates, running 40 cycles with 30 s of denaturation at 95 °C followed by 1 min of annealing and polymerization at 60 °C. Fluorescence emission was detected during the annealing/ extension step in each cycle. After PCR a melting curve analysis of the product was performed, which for all primer sets resulted in single product-specific melting curves with no primer-dimers. Threshold cycle (C t values) from serial dilutions of cDNA was used to construct a standard curve, and the individual real-time PCR amplification efficiency (E = 10 -1/slope ) was calculated from this curve. The relative expression ratio of a target gene was based on its amplification efficiency (E) and the crossing point difference (ΔC t ) for an unknown sample vs. a control.
The geometric mean of the reference genes was used to normalize the raw value of the genes of interest:
where REF means geometric mean RNA quantity of four reference genes and AQP means aquaporin of interest RNA quantity. 
Immunohistochemistry
Tissue was immersed in 10 % formalin for 24 h, washed in PBS buffer, dehydrated and embedded in paraffin wax. Sections of 3 μm were cut, deparaffinized and rehydrated. H&E-staining was performed for orientation. Sections for immunohistochemistry were stained using the Ventana Benchmark Xt® (Ventana Medical Systems, Tucson, USA). Demasking was done using the CC2 protocol for heat induced epitope retrieval. Cell conditioning solution (CC2, Ventana) is a low pH buffer solution which was added to the tissue sections. Sections were then heated to 94 °C for a total of 44 min with addition of further CC2 every four minutes. Primary antibody (AQP1, Alomone Labs, Jerusalem, Israel, cat. no: AQP-001) was diluted 1:1,000 in DAKO diluent and sections were incubated with this for 32 min. Reaction was visualized with the ultraview DAB v3 kit (Ventana). Nuclei were counterstained by hematoxylin and enhanced by bluing agent.
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Western blotting
Bladder tissue was homogenized for 4 min at 50 Hz by a TissueLyser LT (Qiagen, Hilden, Germany) in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM Na 2 EDTA, 1 % Triton X-100, 0.5 % sodium deoxycholate, pH 7.4). Homogenates were centrifuged for 10 min at 1000 G at 4 °C. Using a Pierce BCA protein assay kit (Roche, Basel, Switzerland) the total protein concentrations in the supernatant were measured at 562 nm. Gel samples were prepared using Laemmli sample buffer and loaded on a 12 % Criterion TGX Precast Gel (Bio-Rad Laboratories, Copenhagen, Denmark). From bladder samples 100 μg of protein was added for AQP1 detection. From the renal cortex control a 20 μg sample of protein was added. After electrophoresis proteins were transferred to a Hybond ECL nitrocellulose membrane (GE Healthcare, Hatfield, UK). Blocking was done in 5 % non-fat dry milk dissolved in PBS-Tween 20 (80 mM Na 2 HPO 4 , 20 mM NaH 2 PO 4 , 100 mM NaCl, 0.1 ml Tween 20; pH 7.4). Membranes were washed in PBS-T and incubated with primary antibody overnight at 4 °C (AQP1, Alomone Labs, Jerusalem, Israel, cat. no: AQP-001, 1:500). Horseraddish peroxidase-conjugated secondary antibody (p448 goat anti-rabbit immunoglobulin, DAKO, Glostrup, Denmark) was added and incubated for 1 h at room temperature. Antigen-antibody reactions were visualized using an enhanced chemiluminescence system (Amersham ECL Plus, GE Healthcare, Chicago, USA) and imaged using the Bio-Rad ChemiDoc-MP imaging system, Image Lab software v 5.2.1 (Bio-Rad Laboratories, Copenhagen, Denmark). All Western blots were normalized to GAPDH as a reference protein (GAPDH primary antibody, Cell signals #2118, 1:2,000, 20 μg of protein mounted). Pre-absorption with the control peptide (AQP1, Alomone Labs, Jerusalem, Israel, cat. no: AQP-001) was performed as a negative control.
Statistics
GraphPad Prism 7.0a (GraphPad Software Inc., La Jolla, USA) was used for statistical analyses. Group means were compared by Mann-Whitney test. The null hypothesis was rejected at p<0.05. Outcomes are reported as median and interquartile range (IQR).
Results
Forty-one fetuses at 100 days of gestation were obtained from two sows. Two fetuses from each sow were immediately discarded, due to small size and/or malformed appearance. Two sows at 60 days of gestation carried 26 and 23 fetuses, respectively. Specifications on sex, weight and tissue utilization are listed in Table 2 . 
PCR: Expression of AQP mRNA during development
For PCR we selected fetuses with a complete set of snap frozen samples (urethra, bladder, ureter and renal pelvis). Eight fetuses at 100 days of gestation and eleven fetuses at 60 days of gestation met these criteria. Thus a total of 76 samples from 19 fetuses were included for RNA extraction. RNA was obtained from 71 of these.
AQP1, 3, 9 and 11 mRNA was expressed in all locations. AQP5 mRNA was expressed at low levels in urethra samples from both male and female fetuses, but not in any samples from other locations. We were not able to identify AQP2, 4, 6, 7, 8 shown in Figure 1 . The expression of AQP3 increased significantly at all four locations during gestation, whereas AQP11 mRNA expression significantly decreased at all four locations. In the urethra and bladder we also found a significant increase in the expression of AQP1 and 9 with gestational age. Expression of AQP1 also increased significantly in the ureter whereas AQP9 expression decreased. In the pelvis we did not find significant changes in expression of AQP1 and 9 between gestation day 60 and 100. AQP5 was expressed in the urethra at a low level that did not show significant change through gestation (data not shown). In the 60-day group we observed no significant difference in expression level between sexes, except for AQP3 in the bladder where the male samples showed a slightly higher expression level and AQP1 in the ureter, where the female samples showed a slightly higher expression level (Fig. 1B) . In the 100-day group there were too few male samples to make a valid comparison.
Western blotting: AQP1 in the fetal porcine bladder
For Western blotting we used 8 bladders from fetuses at 60 days of gestation and 7 bladders from fetuses at 100 days of gestation. Renal and bladder tissue from a juvenile pig was used as controls. Results are visualized in Figure 2 and confirm our QPCR data showing significantly higher AQP1 protein levels at day 100 compared to day 60 of gestation. Pre-absorption with the control peptide was performed as a negative control in porcine kidneys and showed that pre-absorption of the AQP1 antibody eliminates the binding of the antibody to the protein in the tissue.
Immunohistochemistry: AQP1 localization in the fetal porcine urinary tract
In order to define how the AQPs were localized we performed immunohistochemistry. Figure 3 shows images from immunohistochemistry. Labelling with AQP1-antibody showed staining in the endothelial cells lining the vessels throughout the bladder wall, as well as vessels in the sub-urothelial layers of the urethra, the ureter and the renal pelvis. AQP3, 5, 9 and 11 protein expression and localization could not be assessed due to the lack of suitable antibodies.
Discussion
The expression and function of AQPs has been examined widely in a number of tissues. However, the urinary tract has not been fully investigated in relation to water channel expression and especially not during fetal development. The present study demonstrates in porcine fetuses the expression of AQP1, 3, 9 and 11 mRNA at four locations along the urinary tract, at two time-points during gestation. In addition, AQP5 mRNA transcript was detected in the urethra. Using Western blot analysis we confirmed increased AQP1 protein level in the bladder with gestational age. Immunohistochemistry showed localization of AQP1 in the endothelial cells lining the vessels throughout the wall of the entire urinary tract.
Previous studies on AQPs in the urinary tract have focused on the expression in the adult mammalian bladder. Vahabi et al. (2015) detected mRNA transcripts of AQP1, 3, 9 and 11 in the juvenile porcine bladder, and confirmed the expressed proteins with immunohistochemistry. This is consistent with our findings showing that these same AQPs are expressed in the fetal porcine bladder already halfway through gestation. Similar to Vahabi et al. (2015) we also observed AQP1 staining in the vessels. Furthermore, this study shows for the first time, that the same four AQPs are expressed in the upper urinary tract and the urethra as well. Rubenwolf et al. (2009) identified transcripts for AQP3, 4, 7, 9 and 11 in the urothelium of the adult human bladder and ureter, and confirmed findings on the protein level with immunohistochemistry for all but AQP11. Our findings are consistent with these results regarding AQP3, 9 and 11, but we were not able to identify AQP4 and 7 in the porcine fetal bladder and ureter. In contrast to Rubenwolf et al. (2009) we demonstrated expression of AQP1. This difference may very well be explained by the fact that Rubenwolf et al. (2009) only studied the urothelial layer -we found AQP1 to be expressed in the vessels of the urinary tract wall, below the urothelium.
Studies on AQP expression during development are scarce. Xing and Nørregaard (2016) have described Vol. 67 increasing expression of AQP1, 2 and 3 in the fetal porcine kidney during gestation. In our study we also observed an increased expression with regards to most of the identified AQPs. In contrast, we found a significant decrease in the expression of AQP11 mRNA at all locations of the urinary tract. We can only speculate on the reasons for this difference, since the functional importance of the AQPs in the urinary tract remains to be established. Involvement in the trans-urothelial transport of water seems to be a reasonable assumption. This assumption was generated through the work done by Nelson and coworkers on the American black bears, showing urine reabsorption from the bladder during hibernation (Nelson 1973 , Nelson et al. 1975 , Nelson et al. 1973 , Spector et al. 2015 . Spector et al. (2002) studied AQPs in adult rats and showed expression of AQP2 and 3 in the urothelium and AQP1 in the suburothelial vessels. Particularly AQP3, but also AQP2, were upregulated in the rats in response to dehydration. Kim et al. (2010 Kim et al. ( , 2013a , investigating expression of AQP1, 2 and 3 in rat urinary bladder after partial bladder outlet obstruction (BOO), found that immunoreactivity of AQP1 in both the control and the BOO groups was localized in the capillaries, arterioles, and venules in the lamina propria of the urinary bladder. The expression of AQP1, 2 and 3 was significantly increased in the BOO group.
It has been speculated whether the AQPs in the bladder are merely regulating local cell volume and tonicity, but these studies indicate that the AQPs might also mediate transport of water between urine and the bloodstream (Kim et al. 2013a , Kim et al. 2010 , Spector et al. 2002 . Further supporting trans-urothelial transport, Rubenwolf et al. (2012b) created a model with cultured human urothelial cells and demonstrated water and urea flux through AQPs, sensitive to osmolality.
Along with several other studies on changes in urine composition during passage and storage in the urinary tract (Cahill et al. 2003 , Englund 1956 , Levinsky and Berliner 1959 , Shafik et al. 2005 , Shafik et al. 2004 , this justifies hypothesizing that adjusting water and salt homeostasis does not stop as the urine leaves the collecting tubules in the kidney, but continues as the urine is transported along the urinary tract and is exposed to the urothelium. It is also an interesting question whether the function of the urinary tract AQPs change from fetal to adult life.
Fetal urine production is greater than in the adult (Ervin et al. 1993) . Furthermore, the urine pathway being continuously "recycled" from the urinary tract into the amniotic cavity and then back into the fetus is certainly different from postnatal life, meaning that it is fair to assume that there may also be differences in the properties of the urinary tract surface from fetal to postnatal life.
Many questions remain unanswered concerning the role of AQPs in the urinary tract. Are they actors in regulating the universal water and salt homeostasis, or are they merely regulating local cell hydration and tonicity? Do they respond to changes in urine composition, stretch of the bladder wall or other factors? Do they have other functions not immediately related to water balance? For example, Rubenwolf and coworkers demonstrated downregulation of AQP3 in urothelial carcinoma and a correlation between AQP3 expression and prognosis (Otto et al. 2012 , Rubenwolf et al. 2015 , 2012a .
There is a need for better understanding not only the developmental aspects with respect to distribution and function of AQPs in the urothelium and sub-urothelial layers, but also their roles postnatally, in normal animals and in urinary tract diseases. Signaling pathways in lower urinary tract dysfunction might also include AQPs. From a clinical perspective, the fact that AQPs can be measured in the urine (Umenishi et al. 2002) and changes in response to bladder conditions, such as infra-vesical obstruction, render them a possible diagnostic or pharmacological target.
Conclusion
The present study shows that several AQPs, e.g. AQP1, 3, 5, 9 and 11 are expressed in the porcine urinary tract already during fetal life. Expression levels change during gestation: AQP11 is downregulated, whereas other AQPs are upregulated in most locations. AQP1 was demonstrated in endothelial cells of vessels in the bladder wall. The functional and developmental consequences of these findings have not been explored, but deserve further study.
